D-Dimer and Thrombin-Antithrombin III Complexes in Patients with Clinically Suspected Pulmonary Embolism

Summary

One hundred and fifty-six consecutive patients with clinically suspected pulmonary embolism (PE) had blood drawn to measure levels of D-dimer and thrombin-antithrombin (TAT) complexes and underwent ventilation/perfusion (V/Q) lung scanning and bilateral impedance plethysmography (IPG); pulmonary angiography was performed in 10 patients. Patients were classified as: PE-positive (positive pulmonary angiography or high probability lung scan or non-high probability lung scan and abnormal IPG) or, PE-negative (normal lung scan or normal pulmonary angiography) or PE-unlikely (non-high probability lung scan and normal serial IPG and absence of venous thromboembolism in follow-up). Thirty patients were classified as PE-positive, 64 as PE-negative and 62 patients as PE-unlikely. PE-positive patients were treated with anticoagulants, whereas PE-negative and PE-unlikely patients were not. PE-unlikely patients were followed for 3 months with repeat IPG and clinical evaluation for the occurrence of venous thromboembolism. The sensitivities, specificities, positive predictive values and negative predictive values of the D-dimer and TAT complex assays were calculated for patients classified as PE-positive and PE-negative. In addition, the prevalences of normal D-dimer and TAT complex assays were calculated for PE-unlikely patients.

Cutoffs of 300 ng/ml for D-dimer and 3.5 μg/ml for TAT complexes provided sensitivities of 96% for both assays, negative predictive values of 97% for D-dimer and 96% for TAT complexes and specificities of 52% for D-dimer and 51% for TAT complexes. The specificities of the assays were higher in patients without comorbid conditions and in outpatients. Among PE-unlikely patients, 14 had normal D-dimer levels and 5 had normal levels of TAT complexes. None of these patients developed venous thromboembolism in follow-up.

Our study indicates that: 1) PE is highly unlikely in patients who have D-dimer levels of less than 300 ng/ml and/or levels of TAT complexes below 3.5 μg/ml, and 2), because of their relatively low positive predictive values, further investigation is required if levels of D-dimer and/or TAT complexes are above these cutoffs. These results should be confirmed in future clinical management trials.

• References

• 1 Hull RD, Raskob GE, Carter CJ. et al Pulmonary embolism in outpatients with pleuritic chest pain. Arch Intern Med 1988; 148: 838-844
• 2 Bell WR, Simon TL, DeMets DL. The clinical features of submassive and massive pulmonary embolism. Am J Med 1977; 62: 355-360
• 3 Hull RD, Hirsh J, Carter CJ. et al Pulmonary angiography, ventilation lung scanning and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med 1983; 98: 891-899
• 4 Hull RD, Raskob GE, Coates G, Panju AA. Clinical validity of a normal perfusion lung scan in patients with suspected pulmonary embolism. Chest 1990; 97: 23-26
• 5 Hull RD, Hirsh J, Carter CJ. et al Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism. Chest 1985; 88: 819-828
• 6 The PIOPED Investigators Value of the ventilation /perfusion scan in acute pulmonary embolism. JAMA 1990; 263: 2753-2759
• 7 Hull RD, Raskob GE, Hirsh J. The diagnosis of clinically suspected pulmonary embolism. Chest 1986; 89: 417s-25s
• 8 Bounameaux H, Slosman D, de Moerloose P, Reber G. Laboratory diagnosis of pulmonary embolism: value of increased levels of plasma D-dimer and thrombin-antithrombin III complexes. Biomed Pharmacother 1989; 43: 385-388
• 9 Bridey F, Philipotteau C, Dreyfus M, Simonneau G. Plasma D-dimer and pulmonary embolism. Lancet 1989; 1: 791-792
• 10 Speiser W, Leitha T, Dudczak R, Lechner K. Letter to the editor. Lancet 1989; 1: 792
• 11 Goldhaber SZ, Vaughan DE, Tumeh SS, Loscalzo J. Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolism. Am Heart J 1988; 116: 505-508
• 12 Bounameaux H, Cirafici P, DeMoerloose P. et al Measurement of D-dimer as diagnostic aid in suspected pulmonary embolism. Lancet 1991; 337: 196-200
• 13 Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemostas 1988; 59: 101-106
• 14 Rowbotham BJ, Carrol P, Whitaker AN. et al Measurement of crosslinked fibrin derivates-use in the diagnostic of venous thrombosis. Thromb Haemostas 1987; 57: 59-61
• 15 Bounameaux H, Schneider PA, Reber G, DeMoerloose P, Krahen-buhl B. Measurement of plasma D-dimer for diagnosis of deep venous thrombosis. AJCP 1989; 91: 82-85
• 16 Heaton DC, Billings JD, Hickton CM. Assessment of D-dimer assays for the diagnosis of deep venous thrombosis. J Lab Clin Med 1987; 110: 588-591
• 17 Hull R, Van Aken WG, Hirsh J. et al Impedance plethysmography using the occlusive cuff technique in the diagnostic of venous thrombosis. Circulation 1976; 58: 696-700
• 18 Hull RD, Raskob G, Coates G, Panju AA, Gill GJ. A new noninvasive management strategy for patients with suspected pulmonary embolism. Arch Intern Med 1989; 2549-2555
• 19 Speiser W, Mallek R, Koppensteiner R. et al D-dimer and TAT measurement in patients with deep venous thrombosis: Utility in diagnosis and judgement of anticoagulant treatment effectiveness. Thromb Haemostas 1990; 64: 196-201